tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yun Zhong, 53 are a BUY (80.3%), 13 are a HOLD (19.7%).
Analyst Yun Zhong, currently employed at WEDBUSH, carries an average stock price target met ratio of 26.33% that have a potential upside of 12.91% achieved within 81 days. Previously, Yun Zhong worked at BTIG.
Yun Zhong’s has documented 120 price targets and ratings displayed on 23 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on KROS, Keros Therapeutics at 06-Nov-2025.
Analyst best performing recommendations are on GRPH (GRAPHITE BIO).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 11/11/2020. The price target of $140 was fulfilled within 2 days with a profit of $5.27 (3.91%) receiving and performance score of 19.56.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 25-Oct-2022
3 years 2 months 17 days ago
(25-Oct-2022)
1/10 (10%)
$13.99 (348.88%)
848
Hold
Since 25-Oct-2022
$0.4
$0.01 (2.56%)
3 years 2 months 17 days ago
(25-Oct-2022)
1/1 (100%)
$0.01 (2.56%)
2
Hold
Since 06-May-2020
3 years 2 months 18 days ago
(24-Oct-2022)
0/2 (0%)
$2.73 (29.45%)
Hold
3 years 2 months 18 days ago
(24-Oct-2022)
0/1 (0%)
$7.55 (308.16%)
Hold
Since 29-Sep-2022
$11
3 years 3 months 13 days ago
(29-Sep-2022)
0/2 (0%)
$6.72 (157.01%)
Which stock is Yun Zhong is most bullish on?
Which stock is Yun Zhong is most reserved on?
What Year was the first public recommendation made by Yun Zhong?
